Biosimilar regional performance Lombardia MS: REMI: 52,8% BIO: 47,2% mar-15 apr-15 mag-15 giu-15 lug-15 ago-15 set-15 ott-15 nov-15 dic-15 gen-16 Feb-16 Mar-16 Apr-16 Mag-16 Giu-16 Lug-16 BIOSIMILAR 67 230 394 419 561 428 743 904 900 1.035 1.024 1.315 1.840 1.626 1.527 1.807 1.958 Remicade 3.500 2.952 2.983 2.712 3.336 2.350 2.878 2.306 2.801 2.237 2.144 2.284 2.565 2.141 2.014 2.045 2.194 Tot 3.567 3.182 3.377 3.131 3.897 2.778 3.621 3.210 3.701 3.272 3.168 3.599 4.405 3.767 3.541 3.852 4.152 Source: IMS IMFO
Infliximab regional performance Lombardia mar-15 apr-15 mag-15 giu-15 lug-15 ago-15 set-15 ott-15 nov-15 dic-15 gen-16 Feb-16 Mar-16 Apr-16 Mag-16 Giu-16 Lug-16 BIOSIMILAR 67 230 394 419 561 428 743 904 900 1.035 1.024 1.315 1.840 1.626 1.527 1.807 1.958 Remicade 3.500 2.952 2.983 2.712 3.336 2.350 2.878 2.306 2.801 2.237 2.144 2.284 2.565 2.141 2.014 2.045 2.194 Tot 3.567 3.182 3.377 3.131 3.897 2.778 3.621 3.210 3.701 3.272 3.168 3.599 4.405 3.767 3.541 3.852 4.152 Source: IMS IMFO